170 related articles for article (PubMed ID: 10688633)
21. Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models.
Remaury A; Raddatz R; Ordener C; Savic S; Shih JC; Chen K; Seif I; De Maeyer E; Lanier SM; Parini A
Mol Pharmacol; 2000 Nov; 58(5):1085-90. PubMed ID: 11040057
[TBL] [Abstract][Full Text] [Related]
22. Impact of species-dependent differences on screening, design, and development of MAO B inhibitors.
Novaroli L; Daina A; Favre E; Bravo J; Carotti A; Leonetti F; Catto M; Carrupt PA; Reist M
J Med Chem; 2006 Oct; 49(21):6264-72. PubMed ID: 17034132
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors.
Reniers J; Robert S; Frederick R; Masereel B; Vincent S; Wouters J
Bioorg Med Chem; 2011 Jan; 19(1):134-44. PubMed ID: 21183355
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo effect of BU99006 (5-isothiocyanato-2-benzofuranyl-2-imidazoline) on I2 binding in relation to MAO: evidence for two distinct I2 binding sites.
Paterson LM; Tyacke RJ; Robinson ES; Nutt DJ; Hudson AL
Neuropharmacology; 2007 Feb; 52(2):395-404. PubMed ID: 17045310
[TBL] [Abstract][Full Text] [Related]
25. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio).
Setini A; Pierucci F; Senatori O; Nicotra A
Comp Biochem Physiol B Biochem Mol Biol; 2005 Jan; 140(1):153-61. PubMed ID: 15621520
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of MAO-B activity and imidazoline receptors in rat brain following chronic treatment of morphine.
Su RB; Li J; Li X; Qin BY
Acta Pharmacol Sin; 2001 Jul; 22(7):639-44. PubMed ID: 11749830
[TBL] [Abstract][Full Text] [Related]
27. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
[TBL] [Abstract][Full Text] [Related]
28. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
[TBL] [Abstract][Full Text] [Related]
29. Monoamine oxidase inhibition by selected anilide derivatives.
Legoabe L; Kruger J; Petzer A; Bergh JJ; Petzer JP
Eur J Med Chem; 2011 Oct; 46(10):5162-74. PubMed ID: 21899930
[TBL] [Abstract][Full Text] [Related]
30. Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues.
Denney RM; Fritz RR; Patel NT; Widen SG; Abell CW
Mol Pharmacol; 1983 Jul; 24(1):60-8. PubMed ID: 6191193
[TBL] [Abstract][Full Text] [Related]
31. Autoradiographic localisation of [3H]2-BFI imidazoline I2 binding sites in mouse brain.
MacInnes N; Handley SL
Eur J Pharmacol; 2005 Jun; 516(2):139-44. PubMed ID: 15925361
[TBL] [Abstract][Full Text] [Related]
32. Thio- and aminocaffeine analogues as inhibitors of human monoamine oxidase.
Booysen HP; Moraal C; Terre'Blanche G; Petzer A; Bergh JJ; Petzer JP
Bioorg Med Chem; 2011 Dec; 19(24):7507-18. PubMed ID: 22055712
[TBL] [Abstract][Full Text] [Related]
33. New pyrazoline bearing 4(3H)-quinazolinone inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
Gökhan-Kelekçi N; Koyunoğlu S; Yabanoğlu S; Yelekçi K; Ozgen O; Uçar G; Erol K; Kendi E; Yeşilada A
Bioorg Med Chem; 2009 Jan; 17(2):675-89. PubMed ID: 19091581
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of monoamine oxidase B by N-methyl-2-phenylmaleimides.
Manley-King CI; Terre'Blanche G; Castagnoli N; Bergh JJ; Petzer JP
Bioorg Med Chem; 2009 Apr; 17(8):3104-10. PubMed ID: 19324554
[TBL] [Abstract][Full Text] [Related]
35. Selective inhibition of monoamine oxidase B by aminoethyl substituted benzyl ethers.
Woodroofe CC; Mostashari R; Lu X; Ramsay RR; Silverman RB
J Enzyme Inhib; 2000; 15(1):11-21. PubMed ID: 10850952
[TBL] [Abstract][Full Text] [Related]
36. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
Youdim MB; Weinstock M
Neurotoxicology; 2004 Jan; 25(1-2):243-50. PubMed ID: 14697899
[TBL] [Abstract][Full Text] [Related]
38. Modeling of substrate-binding region of the active site of monoamine oxidase A.
Veselovsky AV; Medvedev AE; Tikhonova OV; Skvortsov VS; Ivanov AS
Biochemistry (Mosc); 2000 Aug; 65(8):910-6. PubMed ID: 11002183
[TBL] [Abstract][Full Text] [Related]
39. High-throughput screening for monoamine oxidase-A and monoamine oxidase-B inhibitors using one-step fluorescence assay.
Guang HM; Du GH
Acta Pharmacol Sin; 2006 Jun; 27(6):760-6. PubMed ID: 16723097
[TBL] [Abstract][Full Text] [Related]
40. LED fluorescence spectroscopy for direct determination of monoamine oxidase B inactivation.
Castillo J; Hung J; Rodriguez M; Bastidas E; Laboren I; Jaimes A
Anal Biochem; 2005 Aug; 343(2):293-8. PubMed ID: 16004952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
